Information
Learning Objective 1
Identify the varying risks between different ASMs for hepatic, hematologic, and neuropsychiatric/cognitive adverse effects in patients with epilepsy
Learning Objective 2
Critically evaluate and develop monitoring strategies for hepatic, hematologic, and neuropsychiatric/cognitive adverse effects across ASMs in patients with epilepsy
Learning Objective 3
Develop strategies for management of adverse effects, including hepatic, hematologic, and neuropsychiatric/cognitive concerns associated with various ASMs in patients with epilepsy
Target Audience
Advanced Practice Providers (APPs)
Advocates
Behavioral Health Providers
Clinicians
Community Health Workers
Fellows/Trainees
Nurses
Pharmacists
Scientists/Researchers
Social Workers
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
Clinical
First-time Attendees
Research
Young Professionals
Education Credits
1.5 CME1.5 CNE1.5 CPE
Session ID
ADR26
Presentation Id
3451946
Event ID
24056
Session Type
Session

